Detalhe da pesquisa
1.
Relapse of HHV8-positive multicentric Castleman disease following rituximab-based therapy in HIV-positive patients.
Blood
; 129(15): 2143-2147, 2017 04 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-28143881
2.
Effect of previous SARS-CoV-2 infection on humoral and T-cell responses to single-dose BNT162b2 vaccine.
Lancet
; 397(10280): 1178-1181, 2021 03 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-33640037
3.
Previous immune checkpoint inhibitor therapy is associated with decreased COVID-19-related hospitalizations and complications in patients with cancer: Results of a propensity-matched analysis of the OnCovid registry.
Int J Infect Dis
; 139: 13-20, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38029831
4.
Discovery and validation of a novel subgroup and therapeutic target in idiopathic multicentric Castleman disease.
Blood Adv
; 5(17): 3445-3456, 2021 09 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34438448
5.
PD-L1 expressing granulomatous reaction as an on-target mechanism of steroid-refractory immune hepatotoxicity.
Immunotherapy
; 11(7): 585-590, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30943859
6.
Diagnostic criteria schemes for multicentric Castleman disease in 75 cases.
J Acquir Immune Defic Syndr
; 65(2): e80-2, 2014 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24442228